Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;10(4):173-187.
doi: 10.1007/s40472-023-00410-8. Epub 2023 Aug 23.

Multi-omics Approach in Kidney Transplant: Lessons Learned from COVID-19 Pandemic

Hiroki Mizuno  1   2 , Naoka Murakami  1
Affiliations

Multi-omics Approach in Kidney Transplant: Lessons Learned from COVID-19 Pandemic

Hiroki Mizuno et al. Curr Transplant Rep. 2023 Dec.

Abstract

Purpose of review: Multi-omics approach has advanced our knowledge on transplantation-associated clinical outcomes, such as acute rejection and infection, and emerging omics data are becoming available in kidney transplant and COVID-19. Herein, we discuss updated findings of multi-omics data on kidney transplant outcomes, as well as COVID-19 and kidney transplant.

Recent findings: Transcriptomics, proteomics, and metabolomics revealed various inflammation pathways associated with kidney transplantation-related outcomes and COVID-19. Although multi-omics data on kidney transplant and COVID-19 is limited, activation of innate immune pathways and suppression of adaptive immune pathways were observed in the active phase of COVID-19 in kidney transplant recipients.

Summary: Multi-omics analysis has led us to a deeper exploration and a more comprehensive understanding of key biological pathways in complex clinical settings, such as kidney transplantation and COVID-19. Future multi-omics analysis leveraging multi-center biobank collaborative will further advance our knowledge on the precise immunological responses to allograft and emerging pathogens.

Keywords: COVID-19; Gene expression; Immunology; Kidney transplant; Multi-omics; Vaccination.

PubMed Disclaimer

Conflict of interest statement

Declaration Conflict of interest HM and NM declare no competing interests.

Similar articles

See all similar articles

Cited by

References

    1. Chavarot N, Gueguen J, Bonnet G, et al. COVID-19 severity in kidney transplant recipients is similar to nontransplant patients with similar comorbidities. Am J Transplant 2021;21(3):1285–94. 10.1111/ajt.16416. - DOI - PMC - PubMed
    1. Caillard S, Chavarot N, Francois H, et al. Is COVID-19 infection more severe in kidney transplant recipients? Am J Transplant 2021;21(3):1295–303. 10.1111/ajt.16424. - DOI - PMC - PubMed
    1. Avery RK, Chiang TPY, Marr KA, et al. Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: a retrospective cohort. Am J Transplant 2021;21(7):2498–508. 10.1111/ajt.16431. - DOI - PMC - PubMed
    1. Agrawal U, Bedston S, McCowan C, et al. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales. Lancet 2022;400(10360):1305–20. 10.1016/S0140-6736(22)01656-7. - DOI - PMC - PubMed
    1. Bossini N, Alberici F, Delbarba E, et al. Kidney transplant patients with SARS-CoV-2 infection: the Brescia Renal COVID task force experience. Am J Transplant 2020;20(11):3019–29. 10.1111/ajt.16176. - DOI - PMC - PubMed

LinkOut - more resources